Topotecan hydrochloride 4 mg / 4mL Injection 4 mL
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 45963-0615-56 |
|---|---|
| Product NDC | 45963-0615 |
| Generic Drug Name | Topotecan hydrochloride |
| Brand Name | Topotecan hydrochloride |
| Manufacturer | Actavis Pharma, Inc. |
| Strength | 4 mg / 4mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 1 Vial |
| Package Description | 1 VIAL in 1 CARTON (45963-615-56) / 4 mL in 1 VIAL |
| Active Ingredients | Topotecan Hydrochloride |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Topotecan hydrochloride 4 mg / 4mL Injection is tracked under NDC 45963-0615-56 and rolls up into product family 45963-0615. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 1 Vial.
- Manufacturer: Actavis Pharma, Inc..
- Dosage form: Injection.
- Family size: 1 indexed presentation.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Potential alternatives with matching presentation
Open the comparison hub or review package-level listings from 4 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.
View Potential Alternative Hubtopotecan hydrochloride 4 mg / 4mL Injection 4 mL Vial4 package-level listings in the comparison hub.Sample package-level pages in this comparison set
Drug Shortage Information
Public sources include strong public product references for the exact topotecan NDC and one FDA recall page that may help contextualize supply history.
Drug Shortage Index family
View Topotecan hydrochloride in the Drug Shortage IndexCompare related NDC-level product references and family-level shortage context for Topotecan hydrochloride.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Topotecan hydrochloride 4 mg / 4mL Injection 4 mL, NDC 45963-0615-56, is a Actavis Pharma, Inc. 4 mg / 4mL injection presentation packaged as 1 Vial. Historical public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 45963-0615-56
- Digits-only NDC 11: 45963061556
- Possible 10-digit display format: 45963-615-56 (4596361556)
Helpful product links
- Search by brand name: Topotecan hydrochloride
- NDC 11: 45963-0615-56
- Product family NDC: 45963-0615
- VA classification code: AN900
- VA classification code description: ANTINEOPLASTIC,OTHER
- CMOP ID: T0354
- VUID: 4012916